The properties of the pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor were studied on a clone of Chinese hamster ovary cells (CHO) stably transfected with the recombinant receptor. PACAP(l-27), PACAP(l-38) and VIP inhibited [t2% acetyl-Hisl]PACAP (l-27) binding, stimulated cyclic AMP and inpsitol phosphates production and induced [Ca2+]l increase with the same order of potency: PACAP( l-27) = PACAP( l-38) > VIP The concentrations required for half maximal receptor occupancy, IPaand [Ca'+]l increase were not different for both PACAPs (1 nM) and IOO-fold higher than those required for cyclic AMP increase (0.010 nM). These data suggest that the occupancy of a portion of the total receptors available was sufficient for maximal cyclic AMP production but not for maximal IPs production. It is concluded that the possibility of the type I PACAP receptor being coupled to a transduction pathway is not located at the level of the ligand but rather at the level of the G-proteins.
Introduction
Pituitary adenylate cyclase activating polypeptide (PACAP) exists in two forms: PACAP(l-38)-NH2 (PACAP( l-38)) and PACAP( l-27)-NH2 (PACAP( l-27)) (Miyata et al., 1989) exhibiting 68% homology with vasoactive intestinal peptide (VIP).
Two classes of PACAP receptors were identified: the non-selective VIP/F'ACAP receptor, also called the type II receptor corresponding to the previously described VIP receptor and cloned by Ishihara (1992) , and the selective PACAP receptor (type I receptor) identified in various cell types and tumors including neuroblastoma cells (Cauvin et al., 1990) , rat astrocytes , pituitary cells , rat chromaffin cells (Watanabe et al., 1992) , PC12 cells (Deutsch and Sun, 1992) , rat gonadotrope-derived an-1 cells *Corresponding author, Tel.: +32 2 5556210; Fax +32 2 5556230. (Schomerus et al., 1994) , and various rat brain areas (Cauvin et al., 1991) . Type I receptor was recently cloned by several groups 'Morrow et al., 1993; Ogi et al., 1993; Svoboda et al., 1993) and five variants due to alternative splicing of the mRNA were described (Spengler et al., 1994) . Interaction of PACAP and VIP with the receptor activated adenylyl cyclase activity in intact cells in all systems studied so far (Cauvin et al., 1990 (Cauvin et al., , 1991 Gottschall et al., 1990; Tatsuno et al., 1990; Deutsch and Sun, 1992; Watanabe et al., 1992; Schomerus et al., 1994) . Furthermore, PACAP also increased the cytosolic freecalcium concentration [Ca2+] , and stimulated IPa production, [Ca2+]t increase was due either to a cyclic AMP dependent Ca2+ influx in pituitary somatotropes (Rawlings et al., 1993) or to an increase in IPs levels in pituitary gonadotropes (Rawlings et al., 1993 (Rawlings et al., , 1994 , PC12 cells (Deutsch and Sun, 1992) and NB-OK-1 cells (Delporte et al., 1993) . IPs production induced by PACAP was also (Spengler et al., 1994) . Surprisingly, in PC12 cells (Deutsch and Sun, 1992) and in transfected LLC-PKI cells (Spengler et al., 1994) , but not in gonadotropes (Schomerus et al., 1994) or NB-OK-l cells (Delporte et al., 1993), PACAP(l-38) was much more potent than PACAP (l-27) on IP, and [Ca2+]i increase, while VIP was lOO-to lOOO-fold less potent. Spengler et al. (1994) concluded from these data that the same receptor could be differently coupled to two transduction pathways through its occupation by distinct natural ligands.
The aim of our study was to compare, in intact CHO cells stably transfected with the recombinant type I PACAP receptor, the effects of PACAP(l-27), PACAP-(l-38) and VIP on receptor occupancy, cyclic AMP production, IP3 generation and [Ca2+]i changes.
Materials and methods

Construction of the expression plasmid, transjkction, selection and expression in CHO cells
The DNA coding for the rat PACAP receptor was excised from the plasmid pCDM8 (Svoboda et al., 1993) by digestion with Hind111 and Not1 and cloned into the Hin-dII1 and blunted Not1 sites of the mammalian expression vector pNIV187, a derivative of pRc/RSV (Invitrogen) that contains the selectable neomycin phospho-transferase gene, and an expression cassette for dihydrofolate reductase (dhfr), as described by Connors et al. (1988) . The resulting recombinant plasmid was transfected into the CHO cell line DG44 (Urlaub and Chasin, 1980) by electroporation using a gene pulser. Binding of iodinated PACAP and PACAP and VIP stimulated adenylyl cyclase activity were not detected in non-transfected or transfected with a mock construction CHO cells (data not shown). Approximately IO7 cells were pre-incubated on ice for 30 min with 25pg DNA in 0.8 ml of 7 mM sodium phosphate buffer (pH 7.4), containing 272 mM sucrose and 1 mM MgC12. Electroporation was performed at 600 V and 3,uFarad. After electroporation, cells were kept on ice for 10 min, added to 10 ml of culture medium and aliquoted in 96-well plates. Cells were maintained in a minimal essential medium (aMEM+), supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, lOO~g/ml streptomycin with an atmosphere of 95% sir/5% CO;! at 37°C.
Forty-eight hours after transfection, the G4 18 resistant cells were selected by addition of geneticin (G4 18) to a final concentration of 450pg/ml. Selection was done in 96-well plates with 2000-5000 cells per well. To produce sufficient cells for receptor characterization, the clones were then grown to confluency in six-well plates of 35 mm diameter.
The clone used in the present study, hereafter referred to as CHO-PACAPr-c2-10 was obtained without amplification and was selected on the basis of its binding capacity for ['251-acetyl-His']PACAP and its capacity to stimulate adenylyl cyclase.
Verification of the expression of type I PACAP receptor transfected in CHO cells
CHO cells were trypsinized, washed once in culture medium and in PBS and finally centrifuged. Total RNA of the cell pellet was extracted by the guanidinium isothiocyanate method and then centrifuged on a caesium chloride gradient (Morser et al., 1979) . cDNA was synthesized by incubating for 30 min at 37"C, then 30 min at 42°C and finally 5 min at 95°C a mixture (20~11) containing 50 mM Tris-HCI (pH 8.3), 3 mM MgC12, 75 mM KCI, 10 mM DTT, 0.5 mM dATP, 0.5 mM dCTP, 0.5 mM dTTP, 0.5 mM dGTP, 40 units of ribonuclease inhibitor, 0.1 mM random hexanucleotide, &g of total RNA and 200 units of superscript reverse transcriptase (Gibco-BRL, Gent Belgium). The mixture was then diluted twice and 1~1 was submitted to PCR using a PCR core reagent kit and the sense primer 5' TTAACT-TTGTGCTYITCATCGGC 3' and the antisense primer 5' TCCCTCTTGCTGACGTTCTC 3' corresponding to, respectively, the 952-976 and the 1118-l 133 sequences of the PACAP receptor (Spengler et al., 1994) . The PCR was performed in a volume of 20~1 containing concentrated PCR buffer, 2 mM MgC12, 50 ng of each primer, 10 ng of DNA and 0.5 units of TAQ DNA polymerase. The PCR mixture was incubated for 2 min at 95°C (1 cycle), then for 1 min at 95°C 1 min at 60°C and 1 min at 72°C (30 cycles) and finally for 10 min at 72°C (1 cycle). Five microlitres of PCR mixture was submitted to electrophoresis on an agarose gel (1.2%), stained with ethidium bromide.
Cell culture
CHO cells were grown in Dulbecco's medium enriched with 10% FCS. Geneticin (0.5 mg/ml) was maintained in the medium of the stock culture, while subcultures prepared for experiments were done in a medium without geneticin. At confluence, the cells were detached with 0.05% (w/v) porcine trypsin, washed twice by centrifugation and resuspension in Dulbecco's medium. The cell number was counted in a Coulter counter (Coulter Electronics Limited, Luton, UK). The viability of the cells was tested by Trypan blue uptake and lactate dehydrogenase release as described previously (Delporte et al., 1992) .
Peptide radioiodination
[N-Acetyl-Hisl]PACAP( l-27) ([AC-His*] PACAP( l-27)) was radioiodinated by the iodogen technique (Fraker and Speck, 1978) and separated on a Sep-Pak cartridge (Robberecht et al., 1992) . Tracer specific activity was 500 Ci/mmol.
Binding of [125t-N-AC-His1]PACAP(I-27) to CHO-
PACAPr-c2-IO cells
Cells were incubated at 37°C for 15 min, in 600~1 of Dulbecco's medium containing 1 mg/ml HSA, 1 mg/ml bacitracin and 40 000 cpm/assay [1251-Ac-Hisi]PACAP-(l-27) and with or without increasing concentrations of peptides. Non-specific binding was determined in the presence of 1 PM PACAP(l-27). The separation of cell bound and free radioactivities was achieved by rapid filtration through glass-fiber filters (Whatman GF/C) presoaked for 24 h in 0.1% poly(ethyleneimine).
Cyclic AMP assay
CHO-PACAPr-c2-10 cells were incubated at 37°C in 600~1 of Dulbecco's medium, containing 1 mg/ml HSA and 1 mg/ml bacitracin, for 15 min in the presence of different concentrations of peptides. Incubation was stopped by addition of 2 ml of ice-cold absolute ethanol. Samples were then centrifuged at 3000 x g for 20 min. The supernatants were collected and evaporated under nitrogen. The pellets were resuspended in 0.4 ml of 50 mM ammonium acetate buffer (pH 6.2). Cyclic AMP was assayed using a commercial RIA kit. Statistical analysis of differences between two adjacent values in the dose-response curves was performed with Student's paired t-test.
Measurement offree intracellular Ca2+ concentration and in situ calibration in single cells
Cells were loaded with fura-acetoxy methyl ester (2 PM fura-ZAM; Boehringer Mannheim, Germany) during 30 min at 37°C. Fura-fluorescence in single cells was measured using dual-excitation microfluorimetry (Tsien et al., 1985) with a camera based system (Applied Imaging, Birchwood, Warrington, Cheshire, UK). Furaloading and the intensity of the excitation light was kept to the minimum in order to maximally reduce intracellular Ca2+ buffering and potential cell photo damage. Fluorescence of about 25 cells plated on a coverslip were recorded simultaneously and analyzed individually by image analysis. The system was coupled to an inverted fluorescence microscope (Diaphot TDM, Nikon, Tokyo, Japan) equipped with Fluor objectives (CF 20x, Nikon) for epifluorescence. R,, and Rtii, were determined using in situ calibration as described previously (Delporte et al., 1993) . In situ calibration was carried out in a series of 10 cells, and the values obtained were used for the determination of [Ca2+]i in all other cells.
Measurement of inositol tris-phosphates (IPJ in suspended cells
CHO-PACAPr-c2-10 cells were pre-incubated for 72 h at 37°C in the presence of 1 PCi [3H]myo-inositol/ml in Dulbecco's culture medium. The cells were then washed, detached with trypsin, washed twice by centrifugation and resuspension with Dulbecco's medium containing 15 mM LiCl, then resuspended in fresh RPM1 medium containing 15 mM LiCl and pre-incubated for 10 min at 37°C. Aliquots of the cell suspension were incubated for 1 or 15 min in the presence of the tested agents and of 1 mg/ml bacitracin and 1% HSA.
[3H]Inositol phosphates were extracted with trichloroacetic acid (TCA) (5% w/v final concentration). After centrifugation, the precipitate was washed with TCA (5% w/v). TCA was eliminated from the combined supematants by four extractions with diethyl ether. After evaporation of residual ether, 100~1 of 10 mM Tris was added to the extract and IP,, IP2, IP3 and IP4 were separated by anion-exchange chromatography on Dowex AG l-X8 formate, as described by Winand et al. (1991) . IP3 isolated by this procedure consisted mainly, after 1 min incubation of inositol 1,4,5trisphosphate as proved by a commercial radioreceptor assay kit. The radioactivity of each fraction was counted in a Beckman Beta spectrometer (Irvine, CA, USA).
Chemicals
PACAP(l-27), PACAP(l-38) and VIP were synthesized by solid phase methodology with an Automated 43 1 A Applied Biosystems Apparatus (Foster City, CA, USA) and purified by HPLC as previously described (Cauvin et al., 1990) . 3[H]Myo-inositol (spec. act. 18.3 Ci/mmol) was obtained from Amersham International (Bucks, UK). All other reagents were of the highest analytical grade available.
Results
I. Verification of the expression of the PACAP receptor of type I transfected in CHO cells
Total RNA was extracted from CHO cells transfected with the PACAP receptor of type I (CHO-PACAPr-c2-10) (Svoboda et al., 1993) . After RT-PCR, the amplified fragment had a length of 181-bp in the case of CHO-PACAPr-c2-10, as expected (Fig. 1, lane 1) . A 265-bp fragment was obtained in the case of CHO-PACAPr-4-12, a clone expressing the PACAP receptor of type I containing a supplementary cassette of 84-bp designated hop (Fig. 1, lane 2) . As negative control, RT-PCR was performed in the absence of RNA (lane 3).
Receptor characterization
At 37"C, [1251-AC-His1]PACAP(1-27) binding on CHO-PACAPr-c2-10 cells was rapid. Equilibrium was reached after 15 min and remained stable for at least 30 min (data not shown).
PACAP(l-27), PACAP( l-38) and VIP inhibited tracer binding ( Fig. 2A) . The displacement curves were compatible with the presence of one class of receptors and the relative I& were 1.0+0.2nM, 1.1 &0.3nM and 1500 + 370 nM (mean + SEM, n = 3) for PACAP(l-27), PACAP( l-38) and VIP, respectively ( Fig. 2A) .
Cyclic AMP levels
In the presence of 0.1 ,uM PACAP( l-27), cyclic AMP levels increased linearly for 5 min until reaching a plateau that was maintained for at least 20 min (data not shown). Dose-response curves of PACAP( l-27), PACAP( l-38) and VIP were performed at equilibrium. The ECso values were 0.010 * 0.002 nM, 0.016 + 0.003 nM, and 9 * 3 nM (mean 2 SEM, n = 3), respectively (Fig. 2B) . For both PACAPs, there was no statistical difference between the levels obtained at a 1.0 nM of peptide and those obtained at any higher concentration.
Cyclic AMP increased 17-fold in the presence of a maximal concentration of either PACAP(l-27), PACAP( l-38) or VIP.
Cytosolic free Ca2+ concentration
The mean resting [Ca2+li in isolated CHO-PACAPr-c2-10 cells was 121 + 4 nM (mean + SEM; n = 150). Both PACAPs and VIP induced a rapid and monophasic increase in [Ca2+]i in 95% of the cells tested. At optimal PACAP( l-27) concentration (0.1 PM), the peptide induced a 14-fold increase in [Ca2+]i (Fig. 3) . EGTA added 1 min before PACAPs or VIP did not modify the PACAP-induced
[Ca2+]i increase (data not shown) showing that [Ca2+]i increase was not due to extracellular calcium entry. Fig. 4 illustrates the concentration-response relationship of both PACAPs and VIP in terms of peak [Ca2+]i elevations. Optimal concentrations of PACAP( l-27), and VIP induced comparable increases in peak [Ca2+]i above resting levels. The EC50 values of PACAP(l-27), PACAP (l-38) and VIP were 1.1+0.3nM, l.Ok0.3nM and 63117nM (mean + SEM, n = 4), respectively.
[Ca2+]i was not affected either by forskolin (l-100,~M) or by dibutyryl cyclic AMP (1 mM) (data not shown). 
IO-'M PACAP (l-27) 2ooom
Accumulation of inositol t&phosphates (IP,)
IPs levels were measured after either 1 or 15 min in CHO-PACAPr-c2-10 cells suspended in the presence of 10 mM LiCl.
After 1 min incubation, 1 PM PACAP(l-27) and 1 PM PACAP(l-38) increased IPs levels by 104 + 15% and 114 f 17% respectively with corresponding ECsO values of 4.0 2 0.5 nM and 5.0 f 0.4 nM (mean + SEM, n = 5) (Fig. 5A) . The stimulation of IPs synthesis by VIP after 1 min incubation was weak (31 f 13%) and not statistically significant. IPs levels measured after 15 min incubation were increased by 216 + 30%, 280 f 10% and 96 2 5% in response to 1 ,uM PACAP(l-27), 1 ,uM PACAP(l-38) and 1 ,uM VIP, respectively. The ECso values of PACAP( l-27) and PACAP( l-38) were, respectively, 1.4 + 0.2 nM and 1.3 + 0.3 nM (mean f SEM, n = 5) (Fig. 5B) . The dose-response curve to VIP was parallel to those of PACAP(l-27) and PACAP(l-38), suggesting that VIP is a full agonist with an EC5a value close to 1 PM.
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Discussion
In the present study we showed that CHO cells stably transfected with the recombinant PACAP type I receptor (the 'normal' construction described by Svoboda et al. (1993) and Spengler et al. (1994) ) expressed binding sites which recognized PACAP( l-27), PACAP( l-38) and VIP with a potency and a selectivity comparable to that of the native receptor described in several tissues (see Section 1). In the stably transfected cell line, the ECsO values of the stimulation of cyclic AMP production by PACAP(l-27), PACAP(l-38) and VIP were approximately 100 times lower than the I&a values observed in binding studies. This may be interpreted as reflecting an efficient coupling of the receptor to the G, adenylyl cyclase system, i.e. the existence in the transfected cells of spare receptors, the occupancy of about 10% of the receptors allowing a maximal increase in cyclic AMP production. Similar results were observed with the rat secretin receptors stably expressed in CHO cells (Vilardaga et al., 1994) .
PAcAp(l-27), PACAF(l-38) and VIP increased [Ca2+li and IP3 production with the same order of potency: PACAP(l-27) = PACAP(l-38) > VIP. The ECso values for the two effects were quite similar, suggesting that the [Ca'+]i rise resulted from intracellular Ca2+ mobilization due itself to increased IPs production. A direct comparison of the ECso values was difficult, however, because the [Ca2+]i response was rapid and of short duration at variance with IPs production that persisted for 15 min (data not shown). It is likely that PACAP was unable to achieve steady state binding and that this kinetic problem is responsible for the steep dose-effect curves of [Ca2+Ji increase. After 15 min of incubation, the VIP dose-response curve was parallel to those of both PACAPs. For both PACAPs, the IC,, value obtained in binding studies was very similar to the EC50 value on either [Ca2+]i raise or IPs production. These data suggested that there was no amplification process and that there is no receptor reserve for phospholipase C activation.
The effects of both PACAPs and VIP on calcium mobilization and IPs production were not due to an increase in cyclic AMP, since they were not reproduced by 1 mM dibutyryl cyclic AMP, or by I-1OOpM forskolin (data not shown). Similar results were observed in other cell types (Delporte et al., 1993; Tatsuno et al., 1992) . In contrast, in pituitary somatotropes (Rawlings et al., 1993) , the effect of PACAP on [Ca'+]i increase could be mimicked by 8-bromo cyclic AMP.
Both PACAPs have also been shown to increase IPs production with quite similar E&a values in human neuroblastoma NB-OK-1 cells (Delporte et al., 1993) and in rat gonadotrope-derived a-T3-1 cells (Schomerus et al., 1994) . but not in PC12 cells (Deutsch and Sun, 1992) or LLC-PKI cells expressing transiently the rat PACAP receptor (Spengler et al., 1993) where only PACAP(l-38) stimulated IP, production. In the latter studies, there was a complete discrepancy between binding data, cyclic AMP increase and IP, production. A possible explanation for the results of Deutsch and Sun (1992) was the existence of a receptor heterogeneity; besides the PACAP type I receptor, there might be a population of selective PACAP( l-38) receptors, recognizing poorly PACAP( l-27) and VIP, that was not coupled to adenylyl cyclase but coupled to phospholipase C. A PACAP binding site with this selectivity was reported on AR 4-25 pancreatic cells . If we assume the LLC-PKl cells did not respond constitutively to PACAP( l-38), the former explanation can not be valid for the data of Spengler et al. (1994) since they worked on cells transiently transfected with a single PACAP receptor, excluding a priori receptor heterogeneity.
These authors concluded that a single PACAP receptor may couple to different G proteins and that the coupling efficiency depended on the ligand used. This hypothesis may be compatible with our data if the G proteins activating phospholipase C in CHO and LLC-PKl cells are different. If this is the case, the data of Spengler et al. (1994) and our data support the hypothesis that the G protein subtypes are critical for PACAP response in different cells. Since, in Spengler's paper the effect of PACAP(l-27) on inosi-to1 phosphate production occurred at concentrations higher than those required for the total occupancy of the receptors, the hypothesis of a 'non receptor mediated effect' may also be proposed: the basic C-terminal extension of PACAP (l-38) possesses the characteristics of an amphiphilic peptide and, by analogy with mastoparan that directly interacts with Gi (Danilenko et al., 1993) and stimulates phosphoinositide breakdown (Choi et al., 1992) , PACAP could interact, in some membranes (maybe more easily in cells transiently overexpressing receptors), directly with a particular G protein.
We conclude from our study that the possibility of the type I PACAP receptor to be coupled to a transduction pathway is not located at the level of the ligand but rather at the level of the G-proteins. Belgium). Christine Delporte is a recipient of a research fellowship from TELEVIE-FNRS, Brussels, Belgium (grant no. 7.4587.92). Pascale Vertongen is a recipient of a doctoral fellowship from IRSIA, CommunautC Franqaise de Belgique.
